Skip to content
Screener

Precigen PGEN Q4 2025 Annual earnings

Reported March 25, 2026 · After market close

Revenue$4.6MMiss by $3.8M
EPS-$0.01Beat by $0.09
Revenue estimate$8.4M
EPS estimate-$0.10

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$69.2M
EPS estimate$0.09

Financials

Q4 2025

Income statement

See full
Net income-$23.5M-19.1%
EPS (diluted)-$0.01+83.3%

Balance sheet

See full
Cash & equivalents$30.2M+2.4%
Total debt$98.3M+1,686%
Total equity$20.9M-45.7%
Total assets$155.5M+7.0%

Cash flow

See full
Operating cash flow-$23.5M-185%
CapEx$18.0K-98.2%
Free cash flow-$23.5M-153%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.48B+351%
Enterprise value$1.55B+409%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.7×+4.6×
Current ratio3.1×-1.7×

Segments

By segment

See full
Reportable Segment$2.4M—

FAQ

When did Precigen report Q4 2025 earnings?
Precigen (PGEN) reported Q4 2025 earnings on March 25, 2026 after market close.
What were Precigen's Q4 2025 revenue and EPS?
Precigen reported revenue of $4.6M and eps of $-0.01 for Q4 2025.
Did Precigen beat estimates in Q4 2025?
Revenue missed the consensus estimate of $8.4M by $3.8M. EPS beat the consensus estimate of $-0.10 by $0.09.
How did Precigen's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 285.1% from $1.2M a year earlier and eps grew 75.0% from $-0.04.
Where can I find Precigen's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000950103-26-004648) and the 10-K periodic report (0001356090-26-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.